Morphologic and metabolic abnormalities in vertically HIV-infected children and youth. - Wikidata - wikimedia - TriplyDB

Morphologic and metabolic abnormalities in vertically HIV-infected children and youth.

Morphologic and metabolic abnormalities in vertically HIV-infected children and youth.

http://www.wikidata.org/entity/Q37187093

about

Dyslipidemia, Diet and Physical Exercise in Children on Treatment With Antiretroviral Medication in El Salvador: A Cross-sectional Study Getting to 90-90-90 in paediatric HIV: What is needed?Aggregate risk of cardiovascular disease among adolescents perinatally infected with the human immunodeficiency virus.Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045.LIPODYSTROPHY SYNDROME IN HIV-INFECTED CHILDREN ON HAART.Antiretroviral treatment for children with peripartum nevirapine exposure.Longitudinal assessment of metabolic abnormalities in adolescents and young adults with HIV-infection acquired perinatally or in early childhood Body fat redistribution and metabolic abnormalities in HIV-infected patients on highly active antiretroviral therapy: novel insights into pathophysiology and emerging opportunities for treatment.Lipid and glucose alterations in perinatally-acquired HIV-infected adolescents and young adults.Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children.Echocardiography and carotid intima-media thickness among asymptomatic HIV-infected adolescents in Thailand.Body fat distribution in perinatally HIV-infected and HIV-exposed but uninfected children in the era of highly active antiretroviral therapy: outcomes from the Pediatric HIV/AIDS Cohort Study.Using cluster heat maps to investigate relationships between body composition and laboratory measurements in HIV-infected and HIV-uninfected children and young adults Lipid profiles in young HIV-infected children initiating and changing antiretroviral therapy.Metabolic abnormalities and body composition of HIV-infected children on Lopinavir or Nevirapine-based antiretroviral therapy.Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trial Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children.The physical and psychological effects of HIV infection and its treatment on perinatally HIV-infected children High prevalence of lipid abnormalities among antiretroviral-naive HIV-infected Asian children with mild-to-moderate immunosuppression.Assessment of biomarkers of cardiovascular risk among HIV type 1-infected adolescents: role of soluble vascular cell adhesion molecule as an early indicator of endothelial inflammation.High prevalence of lipoatrophy in pre-pubertal South African children on antiretroviral therapy: a cross-sectional study.Associations of Genetically Determined Continental Ancestry With CD4+ Count and Plasma HIV-1 RNA Beyond Self-Reported Race and Ethnicity.Unresolved antiretroviral treatment management issues in HIV-infected children Participation and retention of youth with perinatal HIV infection in mental health research studies: the IMPAACT P1055 psychiatric comorbidity study Cardiac effects in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents: a view from the United States of America.Metabolic complications and treatment of perinatally HIV-infected children and adolescents.Insulin resistance and glucose and lipid concentrations in a cohort of perinatally HIV-infected Latin American children Factors associated with insulin resistance among children and adolescents perinatally infected with HIV-1 in the pediatric HIV/AIDS cohort study.Second-line protease inhibitor-based HAART after failing non-nucleoside reverse transcriptase inhibitor-based regimens in Asian HIV-infected children.Lipid changes in Kenyan HIV-1-infected infants initiating highly active antiretroviral therapy by 1 year of age Adverse bone health among children and adolescents growing up with HIV.Metabolic Disorders in HIV-Infected Adolescents Receiving Protease Inhibitors.Patterns of Growth, Body Composition, and Lipid Profiles in a South African Cohort of Human Immunodeficiency Virus-Infected and Uninfected Children: A Cross-Sectional Study.Nevirapine- Versus Lopinavir/Ritonavir-Based Antiretroviral Therapy in HIV-Infected Infants and Young Children: Long-term Follow-up of the IMPAACT P1060 Randomized Trial.Association of Dyslipidemia and Glucose Abnormalities With Antiretroviral Treatment in a Cohort of HIV-Infected Latin American Children.The Association of Fat and Lean Tissue with Whole Body and Spine Bone Mineral Density is Modified by HIV Status and Sex in Children and Youth.Safety and Efficacy of Atorvastatin in Human Immunodeficiency Virus-infected Children, Adolescents and Young Adults With Hyperlipidemia.Serum lipid and glucose profiles in HIV-positive Nigerian children.Type 2 diabetes and impaired glucose tolerance in two young adults infected with HIV early in life.PHYSICAL ACTIVITY AND BODY FAT IN ADOLESCENTS LIVING WITH HIV: A COMPARATIVE STUDY.

P2860

Q28395417-DD07EE29-9681-49E3-BDE8-EED6EA770EFD Q30385352-E0903AEC-0CFA-43E1-A993-8D6E2E45A9CE Q30576375-CC9649E2-5821-4477-87FB-F4C2EFB0E458 Q33532361-2BE0E08F-10B5-4A81-97DE-8BA6143E1C6B Q34058478-6F62077C-E5B9-4D82-89D6-053060BF6C28 Q34494986-1A3D82C7-340C-4E3D-9EA6-BF2D274C173C Q34495072-B5C7C195-0C0C-4A92-AE7E-8ACC16596C20 Q34564973-8C3BCCEC-F79F-4546-B131-9B7604D9C973 Q35257230-5A322B65-263B-4447-832E-051494CEFF4A Q35549604-425A3B1B-8C4D-41BD-BACF-1369AB1A1EC4 Q35582669-BEA389C7-B3B6-4A34-A436-03D62F532A40 Q35656425-AC62656B-4E60-470E-AD12-6F71373060EE Q35785361-41F78C0C-CA32-446F-8AF5-813E8FB9CF2E Q35926011-81C27599-1A16-42D3-8AEB-00B6B81ADCB4 Q35945312-D83BCA80-6FE6-4455-BA66-743A2D7E15CA Q35965440-E1CA71B9-2B48-4797-9606-3F783EDB8519 Q36238419-BF9E4095-08A5-47A2-A38D-5B5F5E55C4BA Q36349683-169A4C8C-825D-4D0F-A996-330F2B370476 Q36488227-7C95E66E-14BC-4DCA-8202-D6EFBA196317 Q36634946-14C2FBA7-549F-4609-BB14-0FB2047B8428 Q36646867-C0632535-DBAE-46F6-A208-779A2F45F762 Q36678096-0A38658C-7652-448D-AB05-7D5C011AFEC2 Q36781481-F5C3C5BA-7B2C-430B-A263-1975E35F9293 Q36930477-BB6BE2E5-385E-4115-91FE-63EBBF3F388E Q36941650-E36C24EE-E254-45A6-99B0-6255B6A5A174 Q36952291-2FA9DAB0-95D5-41E5-BF44-F9A4F4BF8D14 Q36961612-EB9C75ED-FD8F-4AD9-812A-646653CD6D7F Q36969459-82A259F8-896B-46DC-9BF9-D94652D61EF2 Q37025153-21EEF30C-FDE7-4325-8AE5-EF8D43A4AB24 Q37080086-2A366BA5-BB65-4196-BE82-17A5FE8D0BB6 Q37098360-99BDA771-96C8-498B-B16A-C7BD98A1AB00 Q37673041-E225A72D-D8BF-4ED9-B886-D53622CEFE4C Q38798094-6235453F-EB8B-4FF5-AF0F-365152E8AE03 Q38853723-95AC91E6-EBAD-4AC5-8676-9A8AEC60D3EE Q39444280-D362BACA-14A7-47BF-9714-58639FD70602 Q40089986-28FFAB2F-74D9-4BE4-8626-D0D419F43C66 Q40504034-215E8FDE-5D74-42F5-A3EE-166ED9B63F06 Q42334793-37D139B8-777B-4172-9338-3C890B2A2352 Q42613541-1A51A8F8-AB41-423C-BF57-3639C2889792 Q43089961-65255CEF-675D-4227-82E5-1631B3E6DCE4

P2860

Morphologic and metabolic abnormalities in vertically HIV-infected children and youth.

http://www.wikidata.org/entity/Q37187093

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Morphologic and metabolic abnormalities in vertically HIV-infected children and youth.

@en

Morphologic and metabolic abnormalities in vertically HIV-infected children and youth.

@nl

type

label

Morphologic and metabolic abnormalities in vertically HIV-infected children and youth.

@en

Morphologic and metabolic abnormalities in vertically HIV-infected children and youth.

@nl

prefLabel

Morphologic and metabolic abnormalities in vertically HIV-infected children and youth.

@en

Morphologic and metabolic abnormalities in vertically HIV-infected children and youth.

@nl

P1433

Q37187093-91971A8E-7C91-4AFD-AF1D-CF7DDCB6F584

P1476

Q37187093-1548F0CC-8B7B-46EE-BD55-CA5BCEF1C3FC

P2093

Q37187093-1879C8D4-E63D-4E89-AF47-C1F31BDC58D8

Q37187093-2060DD29-7D67-49D7-98A4-60A47CD8F21D

Q37187093-40A9F7EF-6355-4926-B054-E303A8D19618

Q37187093-50A35B5B-3322-44AB-A57B-9A734DF96F18

Q37187093-5DB0AAED-6005-4513-8156-132778CE3C78

Q37187093-722A3CEB-B14D-4AF2-8C32-3F99FD3F7120

Q37187093-898CFF68-A842-40FD-83F4-E8BD64019F34

Q37187093-9CC6CF22-2C79-457F-BCAC-0DE49071576B

Q37187093-C882FCF5-5D53-4BC4-B03F-A936AB278FCF

Q37187093-DC9D9DF4-8975-4F43-BCF4-B8D106949665

P2860

Q37187093-09046411-B49D-4F3F-AB2E-F09D5FB8803F

Q37187093-0A25E5B8-3029-43BB-95F4-545D1C5A2F9F

Q37187093-0E3EE3C8-CB84-460A-BB5F-9E587A090E1B

Q37187093-1E9AD5D6-1F72-4AE4-A3BD-B631028D723D

Q37187093-1ECB630F-90F3-420E-95D9-9D08B69ABB19

Q37187093-2434DBB9-C627-4C09-86A3-9B22F60452C8

Q37187093-2437AA91-E7D3-4371-8D01-A365C32EFBCF

Q37187093-2912AC48-40BE-4DEF-96F3-85F7E45F2802

Q37187093-29FBA142-A85B-4DF3-A1C7-29A10B60771A

Q37187093-2A65A789-E712-4BB1-975C-665785D49CCE

P304

Q37187093-65819CE4-A4A8-46E7-9156-34E16A851E2C

P31

Q37187093-09AF9315-583B-450C-A2E0-96564FE53C2F

P356

Q37187093-77318839-68B1-48F3-BA7D-794FF0C13B13

P407

Q37187093-DB97A6BC-D884-409D-A9BB-4B0B0D90AC8A

P433

Q37187093-945674A8-5D95-48AD-974C-2D1781D1477C

P478

Q37187093-DFA0DDCF-0A92-4A9E-8713-48C7AEFCAF89

P50

Q37187093-64E94E75-F3E0-4A5C-B117-249A678711E7

P577

Q37187093-D7AF4A60-7798-4A3C-A78F-6E50E0DA9A4B

P698

Q37187093-9F4EDC92-50EA-4BBD-8E84-04847FF1CF10

P921

Q37187093-9560F6BA-0A31-4200-BEB3-AC1830E9F6E0

P932

Q37187093-75721401-C8D9-4F09-BE4F-0267AC11EAD2

P356

QAD.0B013E3283269DFB

P1433

P1476

Morphologic and metabolic abnormalities in vertically HIV-infected children and youth.

@en

P2093

Amanda Zadzilka

http://www.w3.org/2001/XMLSchema#string

Dana S Hardin

http://www.w3.org/2001/XMLSchema#string

Denise L Jacobson

http://www.w3.org/2001/XMLSchema#string

Elizabeth Sheeran

http://www.w3.org/2001/XMLSchema#string

Grace M Aldrovandi

http://www.w3.org/2001/XMLSchema#string

Jane C Lindsey

http://www.w3.org/2001/XMLSchema#string

Kathleen Mulligan

http://www.w3.org/2001/XMLSchema#string

Pediatric AIDS Clinical Trials Group P1045 team

http://www.w3.org/2001/XMLSchema#string

Peggy Borum

http://www.w3.org/2001/XMLSchema#string

William A Meyer

http://www.w3.org/2001/XMLSchema#string

P2860

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Childhood obesity: public-health crisis, common sense cure

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

CDC growth charts: United States

Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study.

Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry.

Exercise training and the cardiovascular consequences of type 2 diabetes and hypertension: plausible mechanisms for improving cardiovascular health.

Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel.

Metabolic complications of antiretroviral therapy in children.

Fat distribution in men with HIV infection.

P304

661-672

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0B013E3283269DFB

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19279441

http://www.w3.org/2001/XMLSchema#string

P921

P932

2680185

http://www.w3.org/2001/XMLSchema#string